Larance, Briony Dr

Head Of

• Board of Management, Drug and Alcohol Multicultural Education Centre Chairperson 2018 -

Member Of

• Illawarra Health and Medical Research Institute 2019 -
• ISLHD Drug and Alcohol Research Committee 2018 -
• SMART Recovery Australia Research Advisory Committee 2018 -

Selected Publications

• Journal Article

  Year	Title
  2019	A population-based study of transdermal fentanyl initiation in Australian clinical practice Published In European Journal of Clinical Pharmacology Volume 75 Pages 401 - 408 ISSN 0031-6970 Altmetric
  2019	Concerns and Help-Seeking Among Patients Using Opioids for Management of Chronic Noncancer Pain Published In Pain Medicine Volume 20 Pages 758 - 769 ISSN 1526-2375 Altmetric
  2019	Post‐marketing studies of pharmaceutical opioid abuse‐deterrent formulations: a framework for research design and reporting Published In Addiction Volume 114 Pages 389 - 399 ISSN 0965-2140 Altmetric
  2019	Regulatory and other responses to the pharmaceutical opioid problem Published In Medical Journal of Australia Volume 210 Pages 6 - 8 ISSN 0025-729X Altmetric
  2019	Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007–2015 Published In Drug and Alcohol Review Volume 38 Pages 159 - 168 ISSN 0959-5236 Altmetric
  2018	A nationwide study of the extent and factors associated with fentanyl use in Australia Published In Research in Social and Administrative Pharmacy Volume 14 Pages 303 - 308 ISSN 1551-7411 Altmetric
  2018	Alcohol use disorder and associated physical health complications and treatment amongst individuals with and without opioid dependence: A case-control study Published In Drug and Alcohol Dependence Volume 188 Pages 304 - 310 ISSN 0376-8716 Altmetric
  2018	Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study Published In The Lancet Public Health Volume 3 Pages e341 - e350 Altmetric
  2018	Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids Published In Pain Medicine Volume 19 Pages 533 - 540 ISSN 1526-2375 Altmetric
  2018	Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol Published In BMJ Open Volume 8 Pages e020006-1 - e020006-6 ISSN 2044-6055 Altmetric
  2018	Perceived stigma and social support in treatment for pharmaceutical opioid dependence Published In Drug and Alcohol Review Volume 37 Pages 262 - 272 ISSN 0959-5236 Altmetric
  2018	Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia Published In CMAJ Volume 190 Pages E355 - E362 ISSN 0820-3946 Altmetric
  2018	Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses Published In Drug and Alcohol Review Volume 37 Pages S203 - S205 ISSN 0959-5236 Altmetric
  2018	Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users Published In Drug and Alcohol Review Volume 37 Pages 664 - 670 ISSN 0959-5236 Altmetric
  2018	Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence Published In Drug and Alcohol Dependence Volume 191 Pages 145 - 151 ISSN 0376-8716 Altmetric
  2018	Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical Claims Published In Pain Medicine Volume 19 Pages 1170 - 1183 ISSN 1526-2375 Altmetric
  2018	The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study Published In The Lancet Psychiatry Volume 5 Pages 155 - 166 Altmetric
  2018	To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia? Published In Pharmacoepidemiology and Drug Safety Volume 27 Pages 550 - 555 ISSN 1053-8569 Altmetric
  2018	Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence Published In Drug and Alcohol Review Volume 37 Pages 887 - 896 ISSN 0959-5236 Altmetric
  2017	Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment Published In Pharmacoepidemiology and Drug Safety Volume 26 Pages 587 - 591 ISSN 1053-8569 Altmetric
  2017	Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids Published In JAMA: Journal of the American Medical Association Volume 317 Pages 967 - 968 ISSN 0098-7484 Altmetric
  2017	Protecting Pain Patients. The Evaluation of a Chronic Pain Educational Intervention Published In Pain Medicine Volume 18 Pages 2306 - 2315 ISSN 1526-2375 Altmetric
  2017	Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015 Published In International Journal of Drug Policy Volume 46 Pages 74 - 78 ISSN 0955-3959 Altmetric
  2016	A Typology of Predictive Risk Factors for Non-Adherent Medication-Related Behaviors among Chronic Non-Cancer Pain Patients Prescribed Opioids: A Cohort Study Published In Pain Physician Volume 19 Pages E421 - E434 ISSN 1533-3159
  2016	A cross‐sectional study of correlates of imprisonment in opioid‐dependent men and women in New South Wales, Australia Published In Drug and Alcohol Review Volume 35 Pages 686 - 692 ISSN 0959-5236 Altmetric
  2016	Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling Published In International Journal of Drug Policy Volume 36 Pages 104 - 111 ISSN 0955-3959 Altmetric
  2016	An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia Published In European Journal of Clinical Pharmacology Volume 72 Pages 469 - 494 ISSN 0031-6970 Altmetric
  2016	Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients? Published In Pain Volume 157 Pages 1489 - 1498 ISSN 0304-3959 Altmetric
  2016	Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale Published In Drug and Alcohol Dependence Volume 159 Pages 42 - 52 ISSN 0376-8716 Altmetric
  2016	Diversion and injection of buprenorphine–naloxone film two years post‐introduction in Australia Published In Drug and Alcohol Review Volume 35 Pages 83 - 91 ISSN 0959-5236 Altmetric
  2016	Geographic Variation in Health Service Use and Perceived Access Barriers for Australian Adults with Chronic Non-Cancer Pain Receiving Opioid Therapy Published In Pain Medicine Volume 17 Pages 2003 - 2016 ISSN 1526-2375 Altmetric
  2016	Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated Published In British Journal of Clinical Pharmacology Volume 82 Pages 1123 - 1133 ISSN 1365-2125 Altmetric
  2016	Opioid agonist treatment for pharmaceutical opioid dependent people (Review) Published In Cochrane Database of Systematic Reviews Volume 5 Pages 1 - 61 ISSN 1469-493X Altmetric
  2016	Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy Published In Drug and Alcohol Dependence Volume 162 Pages 79 - 87 ISSN 0376-8716 Altmetric
  2016	Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study Published In Drug and Alcohol Dependence Volume 166 Pages 125 - 133 ISSN 0376-8716 Altmetric
  2016	Sleep Quality Among People Living With Chronic Noncancer Pain: Findings From the Pain and Opioids IN Treatment (POINT) Cohort Published In Clinical Journal of Pain Volume 32 Pages 380 - 387 ISSN 0749-8047 Altmetric
  2016	The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia Published In Pharmacoepidemiology and Drug Safety Volume 25 Pages 521 - 538 ISSN 1053-8569 Altmetric
  2016	The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine–naloxone film Published In Drug and Alcohol Review Volume 35 Pages 76 - 82 ISSN 0959-5236 Altmetric
  2015	A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia Published In Addiction Volume 110 Pages 646 - 655 ISSN 0965-2140 Altmetric
  2015	A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper‐resistant formulation of controlled‐release oxycodone Published In Pharmacoepidemiology and Drug Safety Volume 24 Pages 1321 - 1333 ISSN 1053-8569 Altmetric
  2015	Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study Published In The Lancet Psychiatry Volume 2 Pages 314 - 322 Altmetric
  2015	Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization Published In Pain Medicine Volume 16 Pages 356 - 366 ISSN 1526-2375 Altmetric
  2015	Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non‐adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol Published In Addiction Volume 110 Pages 226 - 237 ISSN 0965-2140 Altmetric
  2015	Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain Published In Journal of Affective Disorders Volume 184 Pages 72 - 80 ISSN 1573-2517 Altmetric
  2015	Injecting buprenorphine‐naloxone film: Findings from an explorative qualitative study Published In Drug and Alcohol Review Volume 34 Pages 623 - 629 ISSN 0959-5236 Altmetric
  2015	Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids Published In Drug and Alcohol Review Volume 34 Pages 611 - 622 ISSN 0959-5236 Altmetric
  2015	Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation Published In International Journal of Drug Policy Volume 26 Pages 1265 - 1272 ISSN 0955-3959 Altmetric
  2015	Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort Published In Pain Medicine Volume 16 Pages 1745 - 1758 ISSN 1526-2375 Altmetric
  2015	Reducing extramedical use and harms of pharmaceutical opioids: the potential role of abuse-deterrent formulations Published In The Lancet Psychiatry Volume 2 Pages 957 - 959 Altmetric
  2015	The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia Published In BMJ Open Volume 5 Pages e007030-1 - e007030-8 ISSN 2044-6055 Altmetric
  2015	The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain Published In Pain Volume 156 Pages 231 - 242 ISSN 0304-3959 Altmetric
  2015	The characteristics of a cohort who tamper with prescribed and diverted opioid medications Published In Journal of Substance Abuse Treatment Volume 58 Pages 51 - 61 ISSN 0740-5472 Altmetric
  2015	The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study Published In Drug and Alcohol Dependence Volume 151 Pages 56 - 67 ISSN 0376-8716 Altmetric
  2015	The introduction of buprenorphine‐naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations Published In Drug and Alcohol Review Volume 34 Pages 603 - 610 ISSN 0959-5236 Altmetric
  2015	The use of paracetamol (acetaminophen) among a community sample of people with chronic non‐cancer pain prescribed opioids Published In International Journal of Clinical Practice Volume 69 Pages 1366 - 1376 ISSN 1368-5031 Altmetric
  2014	A comparative study of opioid substitution therapy utilisation among opioid‐dependent men and women Published In Drug and Alcohol Review Volume 33 Pages 499 - 505 ISSN 0959-5236 Altmetric
  2014	A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses? Published In Drug and Alcohol Dependence Volume 142 Pages 46 - 55 ISSN 0376-8716 Altmetric
  2014	Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study Published In BMC Pharmacology and Toxicology Volume 15 Pages 17-1 - 17-9 ISSN 2050-6511 Altmetric
  2014	Diversion of prescribed opioids by people living with chronic pain: Results from an Australian community sample Published In Drug and Alcohol Review Volume 33 Pages 27 - 32 ISSN 0959-5236 Altmetric
  2014	Opioid agonist treatment for pharmaceutical opioid dependent people (Protocol) Published In Cochrane Database of Systematic Reviews Volume 5 Pages 1 - 12 ISSN 1469-493X Altmetric
  2014	The diversion and injection of a buprenorphine-naloxone soluble film formulation Published In Drug and Alcohol Dependence Volume 136 Pages 21 - 27 ISSN 0376-8716 Altmetric
  2013	A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence Published In Drug and Alcohol Dependence Volume 131 Pages 119 - 126 ISSN 0376-8716 Altmetric
  2013	Correlates of pain in an in‐treatment sample of opioid‐dependent people Published In Drug and Alcohol Review Volume 32 Pages 489 - 494 ISSN 0959-5236 Altmetric
  2013	Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia Published In Drug and Alcohol Review Volume 32 Pages 468 - 474 ISSN 0959-5236 Altmetric

• Report

  Year	Title
  2015	Understanding the health and service needs of diverse populations of pharmaceutical opioid users: Cohort studies of dependent users in treatment, and people who inject drugs ISBN 9780733435522 Publisher National Drug and Alcohol Research Centre

Investigator On

Year	Title
2019 - 2020	Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views Awarded by: National Centre for Clinical Research on Emerging Drugs (NCCRED) Funding Scheme: Seed Funding
2019	Methamphetamine and mutual support: A mixed methods exploration of SMART Recovery participants' characteristics and opportunities for enhanced referral pathways Awarded by: National Centre for Clinical Research on Emerging Drugs (NCCRED) Funding Scheme: Seed Funding

Other Research Activities

• Farrell, M., Larance, B., Degenhardt, L., Nielsen, S., Shanahan, M., Dunlop, A., Lintzeris, N., Ali, R., Grebely, J., Treloar, C., Dore, G. (2018) Implementation trial of long-acting buprenorphine in community-based treatment settings (CoLAB). Collaborative research grant from Indivior ($1,814,558). 2018 - 2021
• Degenhardt, L., Blyth, F., Mattick, R., Shanahan, M., Cohen, M., Lintzeris, N., Bruno, R., Nielsen, S., Dobbins, T., Larance, B. Pharmaceutical opioids for chronic non-cancer pain: Evaluating health outcomes and economic impact over five years ($775,922, NHMRC Project Grant #1100822) 2016 - 2019

Impact Story

Potential Supervision Topics

• • Substance use disorders and treatment
  • Opioid dependence
  • Mental health and substance use
  • Physical health and substance use
  • Disability, social inclusion and wellbeing
  Dr Larance is available to supervise Masters and PhD projects.

Professional Service Activities

• Illawarra Shoalhaven Local Health District Drug and Alcohol Services Research and Quality Committee Member 2019 -
• SMART Recovery Australia Research Advisory Committee Member 2018 -
• Drug and Alcohol Multicultural Education Centre (DAMEC) Board of Management Chairperson 2017 -

Awards And Honors

• Early Career Researcher Award, conferred by Australasian Professional Society of Alcohol and other Drugs , 2017
• Dean's List Award for PhD Students, conferred by Faculty of Medicine, University of New South Wales, 2010
• Dean's Award for Academic Staff (Research Excellence), conferred by Faculty of Medicine, University of New South Wales

Keywords

• opioids; heroin; opioid dependence; substance use disorders; methamphetamine; abuse deterrent formulations; anabolic steroids; performance and image enhancing drugs; people who inject drugs; methadone; buprenorphine; medication assisted treatment; help-seeking; alcohol and other drugs treatment

Mailing Address

• Room 128a, Building 41

  Northfields Avenue

  Wollongong

  NSW

  2522

  Australia

Orcid Id

• http://orcid.org/0000-0003-3800-7673 (confirmed)

Scopus Id

• 24477825300

Research Areas

• 110319 - PSYCHIATRY (INCL. PSYCHOTHERAPY)
• 1115 - PHARMACOLOGY AND PHARMACEUTICAL SCIENCES
• 1117 - PUBLIC HEALTH AND HEALTH SERVICES
• 111706 - EPIDEMIOLOGY
• 111708 - HEALTH AND COMMUNITY SERVICES
• 111711 - HEALTH INFORMATION SYSTEMS (INCL. SURVEILLANCE)
• 111714 - MENTAL HEALTH
• 170101 - BIOLOGICAL PSYCHOLOGY (NEUROPSYCHOLOGY, PSYCHOPHARMACOLOGY, PHYSIOLOGICAL PSYCHOLOGY)
• 170106 - HEALTH, CLINICAL AND COUNSELLING PSYCHOLOGY

Research Overview

• 
  Dr Larance's specific research interests include the use and extra-medical use of pharmaceutical opioids, 'abuse-deterrent' formulations, treatment of substance use disorders, opioid dependence, the use of anabolic steroids, and interventions to improve the health and wellbeing of people who inject drugs. Her current projects include: developing and validating an opioid-related behaviour scale; a prospective cohort study of people prescribed opioids for non-cancer pain; a post-marketing study of tapentadol; a mixed-methods study to increase the capacity of a Local Health District to respond to methamphetamine-related harm; a feasibility trial of a SMART Recovery app; and an implementation trial of long-acting (depot) buprenorphine for opioid dependence.
  
  

Head Of

• Board of Management, Drug and Alcohol Multicultural Education Centre Chairperson 2018 -

Member Of

• Illawarra Health and Medical Research Institute 2019 -
• ISLHD Drug and Alcohol Research Committee 2018 -
• SMART Recovery Australia Research Advisory Committee 2018 -

Selected Publications

• Journal Article

  Year	Title
  2019	A population-based study of transdermal fentanyl initiation in Australian clinical practice Published In European Journal of Clinical Pharmacology Volume 75 Pages 401 - 408 ISSN 0031-6970 Altmetric
  2019	Concerns and Help-Seeking Among Patients Using Opioids for Management of Chronic Noncancer Pain Published In Pain Medicine Volume 20 Pages 758 - 769 ISSN 1526-2375 Altmetric
  2019	Post‐marketing studies of pharmaceutical opioid abuse‐deterrent formulations: a framework for research design and reporting Published In Addiction Volume 114 Pages 389 - 399 ISSN 0965-2140 Altmetric
  2019	Regulatory and other responses to the pharmaceutical opioid problem Published In Medical Journal of Australia Volume 210 Pages 6 - 8 ISSN 0025-729X Altmetric
  2019	Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007–2015 Published In Drug and Alcohol Review Volume 38 Pages 159 - 168 ISSN 0959-5236 Altmetric
  2018	A nationwide study of the extent and factors associated with fentanyl use in Australia Published In Research in Social and Administrative Pharmacy Volume 14 Pages 303 - 308 ISSN 1551-7411 Altmetric
  2018	Alcohol use disorder and associated physical health complications and treatment amongst individuals with and without opioid dependence: A case-control study Published In Drug and Alcohol Dependence Volume 188 Pages 304 - 310 ISSN 0376-8716 Altmetric
  2018	Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study Published In The Lancet Public Health Volume 3 Pages e341 - e350 Altmetric
  2018	Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids Published In Pain Medicine Volume 19 Pages 533 - 540 ISSN 1526-2375 Altmetric
  2018	Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol Published In BMJ Open Volume 8 Pages e020006-1 - e020006-6 ISSN 2044-6055 Altmetric
  2018	Perceived stigma and social support in treatment for pharmaceutical opioid dependence Published In Drug and Alcohol Review Volume 37 Pages 262 - 272 ISSN 0959-5236 Altmetric
  2018	Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia Published In CMAJ Volume 190 Pages E355 - E362 ISSN 0820-3946 Altmetric
  2018	Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses Published In Drug and Alcohol Review Volume 37 Pages S203 - S205 ISSN 0959-5236 Altmetric
  2018	Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users Published In Drug and Alcohol Review Volume 37 Pages 664 - 670 ISSN 0959-5236 Altmetric
  2018	Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence Published In Drug and Alcohol Dependence Volume 191 Pages 145 - 151 ISSN 0376-8716 Altmetric
  2018	Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical Claims Published In Pain Medicine Volume 19 Pages 1170 - 1183 ISSN 1526-2375 Altmetric
  2018	The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study Published In The Lancet Psychiatry Volume 5 Pages 155 - 166 Altmetric
  2018	To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia? Published In Pharmacoepidemiology and Drug Safety Volume 27 Pages 550 - 555 ISSN 1053-8569 Altmetric
  2018	Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence Published In Drug and Alcohol Review Volume 37 Pages 887 - 896 ISSN 0959-5236 Altmetric
  2017	Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment Published In Pharmacoepidemiology and Drug Safety Volume 26 Pages 587 - 591 ISSN 1053-8569 Altmetric
  2017	Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids Published In JAMA: Journal of the American Medical Association Volume 317 Pages 967 - 968 ISSN 0098-7484 Altmetric
  2017	Protecting Pain Patients. The Evaluation of a Chronic Pain Educational Intervention Published In Pain Medicine Volume 18 Pages 2306 - 2315 ISSN 1526-2375 Altmetric
  2017	Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015 Published In International Journal of Drug Policy Volume 46 Pages 74 - 78 ISSN 0955-3959 Altmetric
  2016	A Typology of Predictive Risk Factors for Non-Adherent Medication-Related Behaviors among Chronic Non-Cancer Pain Patients Prescribed Opioids: A Cohort Study Published In Pain Physician Volume 19 Pages E421 - E434 ISSN 1533-3159
  2016	A cross‐sectional study of correlates of imprisonment in opioid‐dependent men and women in New South Wales, Australia Published In Drug and Alcohol Review Volume 35 Pages 686 - 692 ISSN 0959-5236 Altmetric
  2016	Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling Published In International Journal of Drug Policy Volume 36 Pages 104 - 111 ISSN 0955-3959 Altmetric
  2016	An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia Published In European Journal of Clinical Pharmacology Volume 72 Pages 469 - 494 ISSN 0031-6970 Altmetric
  2016	Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients? Published In Pain Volume 157 Pages 1489 - 1498 ISSN 0304-3959 Altmetric
  2016	Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale Published In Drug and Alcohol Dependence Volume 159 Pages 42 - 52 ISSN 0376-8716 Altmetric
  2016	Diversion and injection of buprenorphine–naloxone film two years post‐introduction in Australia Published In Drug and Alcohol Review Volume 35 Pages 83 - 91 ISSN 0959-5236 Altmetric
  2016	Geographic Variation in Health Service Use and Perceived Access Barriers for Australian Adults with Chronic Non-Cancer Pain Receiving Opioid Therapy Published In Pain Medicine Volume 17 Pages 2003 - 2016 ISSN 1526-2375 Altmetric
  2016	Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated Published In British Journal of Clinical Pharmacology Volume 82 Pages 1123 - 1133 ISSN 1365-2125 Altmetric
  2016	Opioid agonist treatment for pharmaceutical opioid dependent people (Review) Published In Cochrane Database of Systematic Reviews Volume 5 Pages 1 - 61 ISSN 1469-493X Altmetric
  2016	Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy Published In Drug and Alcohol Dependence Volume 162 Pages 79 - 87 ISSN 0376-8716 Altmetric
  2016	Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study Published In Drug and Alcohol Dependence Volume 166 Pages 125 - 133 ISSN 0376-8716 Altmetric
  2016	Sleep Quality Among People Living With Chronic Noncancer Pain: Findings From the Pain and Opioids IN Treatment (POINT) Cohort Published In Clinical Journal of Pain Volume 32 Pages 380 - 387 ISSN 0749-8047 Altmetric
  2016	The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia Published In Pharmacoepidemiology and Drug Safety Volume 25 Pages 521 - 538 ISSN 1053-8569 Altmetric
  2016	The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine–naloxone film Published In Drug and Alcohol Review Volume 35 Pages 76 - 82 ISSN 0959-5236 Altmetric
  2015	A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia Published In Addiction Volume 110 Pages 646 - 655 ISSN 0965-2140 Altmetric
  2015	A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper‐resistant formulation of controlled‐release oxycodone Published In Pharmacoepidemiology and Drug Safety Volume 24 Pages 1321 - 1333 ISSN 1053-8569 Altmetric
  2015	Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study Published In The Lancet Psychiatry Volume 2 Pages 314 - 322 Altmetric
  2015	Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization Published In Pain Medicine Volume 16 Pages 356 - 366 ISSN 1526-2375 Altmetric
  2015	Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non‐adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol Published In Addiction Volume 110 Pages 226 - 237 ISSN 0965-2140 Altmetric
  2015	Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain Published In Journal of Affective Disorders Volume 184 Pages 72 - 80 ISSN 1573-2517 Altmetric
  2015	Injecting buprenorphine‐naloxone film: Findings from an explorative qualitative study Published In Drug and Alcohol Review Volume 34 Pages 623 - 629 ISSN 0959-5236 Altmetric
  2015	Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids Published In Drug and Alcohol Review Volume 34 Pages 611 - 622 ISSN 0959-5236 Altmetric
  2015	Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation Published In International Journal of Drug Policy Volume 26 Pages 1265 - 1272 ISSN 0955-3959 Altmetric
  2015	Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort Published In Pain Medicine Volume 16 Pages 1745 - 1758 ISSN 1526-2375 Altmetric
  2015	Reducing extramedical use and harms of pharmaceutical opioids: the potential role of abuse-deterrent formulations Published In The Lancet Psychiatry Volume 2 Pages 957 - 959 Altmetric
  2015	The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia Published In BMJ Open Volume 5 Pages e007030-1 - e007030-8 ISSN 2044-6055 Altmetric
  2015	The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain Published In Pain Volume 156 Pages 231 - 242 ISSN 0304-3959 Altmetric
  2015	The characteristics of a cohort who tamper with prescribed and diverted opioid medications Published In Journal of Substance Abuse Treatment Volume 58 Pages 51 - 61 ISSN 0740-5472 Altmetric
  2015	The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study Published In Drug and Alcohol Dependence Volume 151 Pages 56 - 67 ISSN 0376-8716 Altmetric
  2015	The introduction of buprenorphine‐naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations Published In Drug and Alcohol Review Volume 34 Pages 603 - 610 ISSN 0959-5236 Altmetric
  2015	The use of paracetamol (acetaminophen) among a community sample of people with chronic non‐cancer pain prescribed opioids Published In International Journal of Clinical Practice Volume 69 Pages 1366 - 1376 ISSN 1368-5031 Altmetric
  2014	A comparative study of opioid substitution therapy utilisation among opioid‐dependent men and women Published In Drug and Alcohol Review Volume 33 Pages 499 - 505 ISSN 0959-5236 Altmetric
  2014	A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses? Published In Drug and Alcohol Dependence Volume 142 Pages 46 - 55 ISSN 0376-8716 Altmetric
  2014	Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study Published In BMC Pharmacology and Toxicology Volume 15 Pages 17-1 - 17-9 ISSN 2050-6511 Altmetric
  2014	Diversion of prescribed opioids by people living with chronic pain: Results from an Australian community sample Published In Drug and Alcohol Review Volume 33 Pages 27 - 32 ISSN 0959-5236 Altmetric
  2014	Opioid agonist treatment for pharmaceutical opioid dependent people (Protocol) Published In Cochrane Database of Systematic Reviews Volume 5 Pages 1 - 12 ISSN 1469-493X Altmetric
  2014	The diversion and injection of a buprenorphine-naloxone soluble film formulation Published In Drug and Alcohol Dependence Volume 136 Pages 21 - 27 ISSN 0376-8716 Altmetric
  2013	A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence Published In Drug and Alcohol Dependence Volume 131 Pages 119 - 126 ISSN 0376-8716 Altmetric
  2013	Correlates of pain in an in‐treatment sample of opioid‐dependent people Published In Drug and Alcohol Review Volume 32 Pages 489 - 494 ISSN 0959-5236 Altmetric
  2013	Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia Published In Drug and Alcohol Review Volume 32 Pages 468 - 474 ISSN 0959-5236 Altmetric

• Report

  Year	Title
  2015	Understanding the health and service needs of diverse populations of pharmaceutical opioid users: Cohort studies of dependent users in treatment, and people who inject drugs ISBN 9780733435522 Publisher National Drug and Alcohol Research Centre

Investigator On

Year	Title
2019 - 2020	Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views Awarded by: National Centre for Clinical Research on Emerging Drugs (NCCRED) Funding Scheme: Seed Funding
2019	Methamphetamine and mutual support: A mixed methods exploration of SMART Recovery participants' characteristics and opportunities for enhanced referral pathways Awarded by: National Centre for Clinical Research on Emerging Drugs (NCCRED) Funding Scheme: Seed Funding

Other Research Activities

• Farrell, M., Larance, B., Degenhardt, L., Nielsen, S., Shanahan, M., Dunlop, A., Lintzeris, N., Ali, R., Grebely, J., Treloar, C., Dore, G. (2018) Implementation trial of long-acting buprenorphine in community-based treatment settings (CoLAB). Collaborative research grant from Indivior ($1,814,558). 2018 - 2021
• Degenhardt, L., Blyth, F., Mattick, R., Shanahan, M., Cohen, M., Lintzeris, N., Bruno, R., Nielsen, S., Dobbins, T., Larance, B. Pharmaceutical opioids for chronic non-cancer pain: Evaluating health outcomes and economic impact over five years ($775,922, NHMRC Project Grant #1100822) 2016 - 2019

Impact Story

Potential Supervision Topics

• • Substance use disorders and treatment
  • Opioid dependence
  • Mental health and substance use
  • Physical health and substance use
  • Disability, social inclusion and wellbeing
  Dr Larance is available to supervise Masters and PhD projects.

Professional Service Activities

• Illawarra Shoalhaven Local Health District Drug and Alcohol Services Research and Quality Committee Member 2019 -
• SMART Recovery Australia Research Advisory Committee Member 2018 -
• Drug and Alcohol Multicultural Education Centre (DAMEC) Board of Management Chairperson 2017 -

Awards And Honors

• Early Career Researcher Award, conferred by Australasian Professional Society of Alcohol and other Drugs , 2017
• Dean's List Award for PhD Students, conferred by Faculty of Medicine, University of New South Wales, 2010
• Dean's Award for Academic Staff (Research Excellence), conferred by Faculty of Medicine, University of New South Wales

Keywords

• opioids; heroin; opioid dependence; substance use disorders; methamphetamine; abuse deterrent formulations; anabolic steroids; performance and image enhancing drugs; people who inject drugs; methadone; buprenorphine; medication assisted treatment; help-seeking; alcohol and other drugs treatment

Mailing Address

• Room 128a, Building 41

  Northfields Avenue

  Wollongong

  NSW

  2522

  Australia

Orcid Id

• http://orcid.org/0000-0003-3800-7673 (confirmed)

Scopus Id

• 24477825300